[REGN] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
03-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -12.47%
YoY- -72.50%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 3,162,100 3,414,400 2,936,200 2,857,200 2,965,100 4,951,700 3,452,800 -5.69%
PBT 858,000 1,324,700 1,509,800 963,200 1,061,100 2,503,400 1,816,600 -39.37%
Tax 40,200 127,600 194,100 111,100 87,600 274,400 184,400 -63.81%
NP 817,800 1,197,100 1,315,700 852,100 973,500 2,229,000 1,632,200 -36.94%
Tax Rate -4.69% -9.63% -12.86% -11.53% -8.26% -10.96% -10.15% -
Total Cost 2,344,300 2,217,300 1,620,500 2,005,100 1,991,600 2,722,700 1,820,600 18.37%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin 25.86 35.06 44.81 29.82 32.83 45.01 47.27 -33.13%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS 7.64 11.19 11.66 7.47 8.61 20.99 15.37 -37.27%
EPS Diluted 7.17 10.50 11.66 7.47 8.61 19.69 14.33 -37.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.